BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6

• Press Releases

  Asgard Therapeutics announces publication in Immunity demonstrating induction of cancer-fighting tertiary lymphoid structures across seven tumor types – and will present new AT-108 biomarker data at SITC 2026

  November 4, 2026

   · 

  6 min read
• Press Releases

  Moleculin Announces Acceptance of Annamycin Data for Presentation at the 2026 American Society of Hematology (ASH) Annual Meeting

  November 4, 2026

   · 

  6 min read
• Press Releases

  Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study

  November 4, 2026

   · 

  5 min read
• Press Releases

  Taiho Oncology and Taiho Pharmaceutical to Present Data from AZTOUND Trial Evaluating Oral Azacitidine and Cedazuridine in Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia at the 68th American Society of Hematology Annual Meeting

  November 4, 2026

   · 

  9 min read
• Press Releases

  Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026

  November 4, 2026

   · 

  3 min read
• Press Releases

  Neion Bio Taps John Maga as Head of Biologics and CMC to Expand Capabilities In Innovative Development

  November 4, 2026

   · 

  4 min read
• 

  Deals

  Boehringer bets big on China, offering $7B biobucks for Sino cancer programs

  Boehringer Ingelheim is building up its China strategy, inking a deal to develop new cancer treatments with Sino Biopharmaceutical just weeks after opening an R&D facility in Shanghai.

  November 4, 2026

   · 

  1 min read

   · 

  Gabrielle Masson
• Press Releases

  ImmunoGenesis to Present IND-Enabling Development Progress and Therapeutic Potential of IMGS-203, a Novel STING Agonist, at SITC 2026 Annual Meeting

  November 4, 2026

   · 

  2 min read
• Press Releases

  Citius Oncology’s Positive Quality of Life Data for LYMPHIR® (denileukin diftitox-cxdl) in Relapsed or Refractory Cutaneous T-Cell Lymphoma Presented at Premier Global CLTG Congress in Europe

  November 4, 2026

   · 

  11 min read
• Press Releases

  Gene Preserves Bone Stem Cell Supply Throughout Life

  November 4, 2026

   · 

  5 min read